Literature DB >> 11282703

Urinary free cortisol in chronic fatigue syndrome.

A J Cleare1, D Blair, S Chambers, S Wessely.   

Abstract

OBJECTIVE: The authors measured 24-hour urinary free cortisol in a group of well-characterized patients with chronic fatigue syndrome.
METHOD: They obtained 24-hour urine collections from 121 consecutive clinic patients with chronic fatigue syndrome and 64 comparison subjects without the syndrome.
RESULTS: Urinary free cortisol was significantly lower in the subjects with chronic fatigue syndrome regardless of the presence or absence of current or past comorbid psychiatric illness. Lower levels of urinary free cortisol were not related to medication use, sleep disturbance, or disability levels.
CONCLUSIONS: There is mild hypocortisolism in chronic fatigue syndrome. Whether a primary feature or secondary to other factors, hypocortisolism may be one factor contributing to the symptoms of chronic fatigue syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282703     DOI: 10.1176/appi.ajp.158.4.641

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

Review 1.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Chronic fatigue.

Authors:  Riccardo Baschetti
Journal:  CMAJ       Date:  2006-08-15       Impact factor: 8.262

3.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Authors:  M J Robertson; R S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; J Ritz; A L Komaroff
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 4.  Neuroendocrine and immune contributors to fatigue.

Authors:  Marni N Silverman; Christine M Heim; Urs M Nater; Andrea H Marques; Esther M Sternberg
Journal:  PM R       Date:  2010-05       Impact factor: 2.298

5.  Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model.

Authors:  Marielly Cuevas; Idhaliz Flores; Kenira J Thompson; Dinah L Ramos-Ortolaza; Annelyn Torres-Reveron; Caroline B Appleyard
Journal:  Reprod Sci       Date:  2012-04-23       Impact factor: 3.060

6.  Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

Authors:  H. M. Van Praag
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 7.  Interrelation between Neuroendocrine Disturbances and Medical Complications Encountered during Rehabilitation after TBI.

Authors:  Caroline I E Renner
Journal:  J Clin Med       Date:  2015-09-22       Impact factor: 4.241

8.  The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Authors:  Tayfun Turan; Hasan Basri Izgi; Saliha Ozsoy; Fatih Tanrıverdi; Mustafa Basturk; Akif Asdemir; Aslı Beşirli; Ertugrul Esel; Seher Sofuoglu
Journal:  Psychiatry Investig       Date:  2009-06-23       Impact factor: 2.505

9.  A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome.

Authors:  S Alexander; O Minton; P Andrews; P Stone
Journal:  Eur J Cancer       Date:  2008-10-30       Impact factor: 9.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.